The Maharashtra government told the state Legislative Assembly on Friday that the licenses of six manufacturers of cough syrups in the state have been suspended for not following the rules.
Food and Drugs Administration Minister Sanjay Rathod made the statement while replying to a calling attention notice by Ashish Shelar (BJP) and others. Recently, a cough syrup made by a Noida-based firm was alleged to have caused the death of 18 children in Uzbekistan. Noida police on Friday said they had arrested three employees of the firm. Rathod said that the Maharashtra government had initiated inquiry against 84 out of 108 manufacturers of cough syrups in the state.
Four of them were directed to stop production while the licences of six companies were suspended, he said. As many as 17 firms were served show-cause notices for violation of rules, the minister added. Shelar referred to the deaths of 66 children in Gambia allegedly because of cough syrups imported from India. But the minister said that the company which was facing the charge of violation of rules in that case was based in Haryana and had no manufacturing unit in Maharashtra.
"We have, however, taken a strict action against the violators of rules. We are ensuring that the World Health Organization's GMP (good manufacturing practises) certification-related rules and Certificate of Pharmaceutical Products are complied with while exporting products (from the state)," he added. Presiding officer Sanjay Shirsat said if 20 per cent of manufacturers faced raids because of suspected violation of rules, it needs to be taken very seriously as it was akin to playing with people's lives. Rathod said of 996 allopathic drug manufacturers in the state, 514 manufacturers export their products.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)